Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Df 526
2. Df-526
3. Dipropizine
4. Dipropizine, (s)-isomer
5. Ditustat
6. Dropropizine
7. Levotuss
8. Tautoss
9. Zyplo
1. 99291-25-5
2. (s)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
3. Levotuss
4. Danka
5. (-)-dropropizine
6. Levdropropizine
7. (s)-(-)-dropropizine
8. Rapitux
9. Levodropropizina
10. (2s)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
11. Levodropropizinum
12. Levopront
13. Levodropropizine [inn]
14. L-dropropizine
15. Dipropizine, (s)-isomer
16. 99291-24-4
17. Dropropizine, (s)-
18. (-)-(s)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol
19. 1,2-propanediol, 3-(4-phenyl-1-piperazinyl)-, (2s)-
20. Chebi:82722
21. 3o31p6t4g3
22. Df-526
23. Levodropropizine (inn)
24. Dropropizine S-form
25. Levodropropizinum [inn-latin]
26. Levodropropizina [inn-spanish]
27. Df 526
28. Levodropropizine [inn:ban]
29. Salvituss
30. Unii-3o31p6t4g3
31. Levopront (tn)
32. (s)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol
33. Cas-17692-31-8
34. S(-)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
35. Lvdp
36. Levodropropizine Impurity A
37. Schembl29043
38. Chembl1288810
39. Dtxsid8023210
40. Levodropropizine [mart.]
41. 1,2-propanediol, 3-(4-phenylpiperazin-1-yl)-, S(-)-
42. Dropropizine S-form [mi]
43. Levodropropizine [who-dd]
44. Levodropropizine (s-dropropizine)
45. Hms3885b07
46. Hy-b1895
47. Bbl036696
48. Mfcd00866852
49. S4131
50. Stl559075
51. Zinc19594545
52. Akos015889397
53. Ac-2084
54. Ac-8088
55. Bcp9000850
56. Ccg-266840
57. Cs-5212
58. Db12472
59. Levodropropizine [ep Monograph]
60. Ncgc00016730-01
61. Ncgc00018230-01
62. Ncgc00018230-06
63. As-12822
64. Bcp0726000048
65. L0339
66. D08119
67. F15098
68. 291l244
69. A845991
70. Ao-022/43512153
71. Q408131
72. Q-100916
73. Brd-k83551379-001-02-6
74. S-(-)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
75. (2s)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol
76. 1,2-propanediol, 3-(4-phenyl-1-piperazinyl)-, (s)-
Molecular Weight | 236.31 g/mol |
---|---|
Molecular Formula | C13H20N2O2 |
XLogP3 | 0.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 236.152477885 g/mol |
Monoisotopic Mass | 236.152477885 g/mol |
Topological Polar Surface Area | 46.9 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 212 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
R - Respiratory system
R05 - Cough and cold preparations
R05D - Cough suppressants, excl. combinations with expectorants
R05DB - Other cough suppressants
R05DB27 - Levodropropizine
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
60
PharmaCompass offers a list of Levodropropizine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levodropropizine manufacturer or Levodropropizine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levodropropizine manufacturer or Levodropropizine supplier.
PharmaCompass also assists you with knowing the Levodropropizine API Price utilized in the formulation of products. Levodropropizine API Price is not always fixed or binding as the Levodropropizine Price is obtained through a variety of data sources. The Levodropropizine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levotuss manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levotuss, including repackagers and relabelers. The FDA regulates Levotuss manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levotuss API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levotuss manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levotuss supplier is an individual or a company that provides Levotuss active pharmaceutical ingredient (API) or Levotuss finished formulations upon request. The Levotuss suppliers may include Levotuss API manufacturers, exporters, distributors and traders.
click here to find a list of Levotuss suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levotuss Drug Master File in Korea (Levotuss KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levotuss. The MFDS reviews the Levotuss KDMF as part of the drug registration process and uses the information provided in the Levotuss KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levotuss KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levotuss API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levotuss suppliers with KDMF on PharmaCompass.
A Levotuss CEP of the European Pharmacopoeia monograph is often referred to as a Levotuss Certificate of Suitability (COS). The purpose of a Levotuss CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levotuss EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levotuss to their clients by showing that a Levotuss CEP has been issued for it. The manufacturer submits a Levotuss CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levotuss CEP holder for the record. Additionally, the data presented in the Levotuss CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levotuss DMF.
A Levotuss CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levotuss CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levotuss suppliers with CEP (COS) on PharmaCompass.
Levotuss Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levotuss GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levotuss GMP manufacturer or Levotuss GMP API supplier for your needs.
A Levotuss CoA (Certificate of Analysis) is a formal document that attests to Levotuss's compliance with Levotuss specifications and serves as a tool for batch-level quality control.
Levotuss CoA mostly includes findings from lab analyses of a specific batch. For each Levotuss CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levotuss may be tested according to a variety of international standards, such as European Pharmacopoeia (Levotuss EP), Levotuss JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levotuss USP).